Select Publications
Journal articles
2023, 'A Mobile Clinical Decision Support System for High-Risk Pregnant Women in Rural India (SMARThealth Pregnancy): Pilot Cluster Randomized Controlled Trial', JMIR Formative Research, 7, http://dx.doi.org/10.2196/44362
,2023, 'Challenges and opportunities in interventions for chronic kidney disease of unknown origin (CKDu): report from the International Society of Nephrology Consortium of Collaborators on CKDu', Kidney International, 103, pp. 6 - 12, http://dx.doi.org/10.1016/j.kint.2022.10.013
,2023, 'Developing Standard Treatment Workflows—way to universal healthcare in India', Frontiers in Public Health, 11, http://dx.doi.org/10.3389/fpubh.2023.1178160
,2023, 'Effect of Vitamin D Supplementation on Serum Hepcidin Levels in Non‑Diabetic Chronic Kidney Disease Patients', Indian Journal of Nephrology, 33, pp. 444 - 448, http://dx.doi.org/10.4103/ijn.ijn_28_23
,2023, 'Indian TrANslational GlomerulonephrItis BioLogy nEtwork (I.TANGIBLE): Design and Methods', Indian Journal of Nephrology, 33, pp. 277 - 282, http://dx.doi.org/10.4103/ijn.ijn_305_23
,2023, 'Renal Revolution: Anticipating the Next 25 Years of India's Kidney Care', Indian Journal of Nephrology, 33, http://dx.doi.org/10.4103/ijn.ijn_125_23
,2023, 'Translating the efficacy of dapagliflozin in chronic kidney disease to lower healthcare resource utilization and costs: a medical care cost offset analysis', Journal of Medical Economics, 26, pp. 1407 - 1416, http://dx.doi.org/10.1080/13696998.2023.2264715
,2023, 'Trends in the Global Burden of Glomerulonephritis', Clinical Journal of the American Society of Nephrology, 18, pp. 14 - 16, http://dx.doi.org/10.2215/CJN.0000000000000029
,2023, 'A Randomized Trial of Nafamostat for Covid-19.', NEJM Evid, 2, pp. EVIDoa2300132, http://dx.doi.org/10.1056/EVIDoa2300132
,2023, 'Association of N-Terminal Pro-Brain Natriuretic Peptide (NT-proBNP) with the Progression of CKD in Indian CKD Cohort', Journal of the American Society of Nephrology, 34, pp. 389 - 389, http://dx.doi.org/10.1681/asn.20233411s1389a
,2023, 'Atacicept 150 mg Reduces Serum Gd-IgA1, a Biomarker Associated with Long-Term Outcomes in IgA Nephropathy (IgAN): 36W Results from the Ph2b ORIGIN Study', Journal of the American Society of Nephrology, 34, pp. 974 - 975, http://dx.doi.org/10.1681/asn.20233411s1974c
,2023, 'Effect of Cholecalciferol Supplementation on Immune Modulation, Inflammation, and Vascular Function in CKD', Journal of the American Society of Nephrology, 34, pp. 676 - 676, http://dx.doi.org/10.1681/asn.20233411s1676a
,2023, 'Hemoglobin Stability in the ASCEND-TD Trial', Journal of the American Society of Nephrology, 34, pp. 75 - 76, http://dx.doi.org/10.1681/asn.20233411s175d
,2023, 'Intact Fibroblast Growth Factor 23 and Progression of CKD', Journal of the American Society of Nephrology, 34, pp. 389 - 389, http://dx.doi.org/10.1681/asn.20233411s1389b
,2023, 'Patterns of multimorbidity among a community-based cohort in rural India.', J Multimorb Comorb, 13, pp. 26335565221149623, http://dx.doi.org/10.1177/26335565221149623
,2023, 'Transparent reporting of adaptive clinical trials using concurrently randomised cohorts.', BMJ Med, 2, pp. e000497, http://dx.doi.org/10.1136/bmjmed-2023-000497
,2023, 'WCN23-0069 EFFICACY AND SAFETY OF REDUCED-DOSE ORAL METHYLPREDNISOLONE IN IGA NEPHROPATHY: THE TESTING TRIAL', Kidney International Reports, 8, pp. S51 - S52, http://dx.doi.org/10.1016/j.ekir.2023.02.118
,2023, 'WCN23-0146 CHOLECALCIFEROL SUPPLEMENTATION IN CHRONIC KIDNEY DISEASE: EFFECT ON IMMUNE AND VASCULAR FUNCTION', Kidney International Reports, 8, pp. S232 - S232, http://dx.doi.org/10.1016/j.ekir.2023.02.521
,2023, 'WCN23-0200 PREVALENCE AND TREATMENT PATTERNS OF ANAEMIA IN INDIVIDUALS WITH CHRONIC KIDNEY DISEASE ACROSS ASIA', Kidney International Reports, 8, pp. S135 - S136, http://dx.doi.org/10.1016/j.ekir.2023.02.309
,2023, 'WCN23-0576 SOLUBLE UROKINASE RECEPTOR (suPAR) LEVELS AND INCIDENT CHRONIC KIDNEY DISEASE IN STOP-CKDu COHORT', Kidney International Reports, 8, pp. S173 - S174, http://dx.doi.org/10.1016/j.ekir.2023.02.390
,2023, 'WCN23-0776 BARRIERS TO ACCESSING ESSENTIAL MEDICINES IN NEPHROLOGY AND RELATED NON-COMMUNICABLE DISEASES: A SCOPING REVIEW', Kidney International Reports, 8, pp. S239 - S239, http://dx.doi.org/10.1016/j.ekir.2023.02.539
,2023, 'WCN23-0955 Performance of latest eGFR equations in Indian population', Kidney International Reports, 8, pp. S124 - S125, http://dx.doi.org/10.1016/j.ekir.2023.02.282
,2023, 'WCN23-0960 ASSESSMENT OF CAUSES OF DEATH IN A POPULATION REPRESENTATIVE COHORT AT RISK OF CHRONIC KIDNEY DISEASE OF UNKNOWN ORIGIN, USING SmartVA TECHNOLOGY', Kidney International Reports, 8, pp. S179 - S180, http://dx.doi.org/10.1016/j.ekir.2023.02.400
,2023, 'WCN23-0985 INCIDENTAL DISCOVERY AND EXTRACTION OF MIGRATED GUIDEWIRE FROM RIGHT FEMORAL VEIN CATHETERIZATION: A CASE REPORT', Kidney International Reports, 8, pp. S334 - S335, http://dx.doi.org/10.1016/j.ekir.2023.02.747
,2023, 'WCN23-1128 Allopurinol for CVD in CKD (AvoiD-CKD): Baseline characteristics from a double blind, randomized controlled trial', Kidney International Reports, 8, pp. S160 - S160, http://dx.doi.org/10.1016/j.ekir.2023.02.361
,2022, 'Renin-angiotensin blocker use is associated with improved cardiovascular mortality in Indian patients with mild-moderate chronic kidney disease—findings from the ICKD study', Frontiers in Medicine, 9, http://dx.doi.org/10.3389/fmed.2022.1060148
,2022, 'ASCOT ADAPT study of COVID-19 therapeutics in hospitalised patients: an international multicentre adaptive platform trial', Trials, 23, http://dx.doi.org/10.1186/s13063-022-06929-y
,2022, 'Controlled evaLuation of Angiotensin Receptor Blockers for COVID-19 respIraTorY disease (CLARITY): statistical analysis plan for a randomised controlled Bayesian adaptive sample size trial', Trials, 23, pp. 361, http://dx.doi.org/10.1186/s13063-022-06167-2
,2022, 'Epidemiology of peritoneal dialysis outcomes', Nature Reviews Nephrology, 18, pp. 779 - 793, http://dx.doi.org/10.1038/s41581-022-00623-7
,2022, 'Peritoneal catheter insertion: combating barriers through policy change', Clinical Kidney Journal, 15, pp. 2177 - 2185, http://dx.doi.org/10.1093/ckj/sfac136
,2022, 'Serum myo-inositol oxygenase levels at hospital discharge predict progression to chronic kidney disease in community-acquired acute kidney injury', Scientific Reports, 12, http://dx.doi.org/10.1038/s41598-022-17599-w
,2022, 'Anticoagulation and Antiplatelet Strategies in Non-Critically Ill Patients with Covid-19', BLOOD, 140, http://dx.doi.org/10.1182/blood-2022-168448
,2022, 'Should More Patients with Kidney Failure Bring Treatment Home? What We Have Learned from COVID-19', Kidney Diseases, 8, pp. 357 - 367, http://dx.doi.org/10.1159/000525046
,2022, 'Barriers to accessing essential medicines for kidney disease in low- and lower middle–income countries', Kidney International, 102, pp. 969 - 973, http://dx.doi.org/10.1016/j.kint.2022.07.029
,2022, 'Chronology of disc degeneration and facet joint arthritis in lumbar spine is variable - A CT based cross-sectional study', Journal of Orthopaedic Science, 27, pp. 1197 - 1202, http://dx.doi.org/10.1016/j.jos.2021.07.016
,2022, 'Impact of the COVID-19 pandemic on the kidney community: lessons learned and future directions', Nature Reviews Nephrology, 18, pp. 724 - 737, http://dx.doi.org/10.1038/s41581-022-00618-4
,2022, 'Interventional nephrology and vascular access practice: A perspective from South and Southeast Asia', Journal of Vascular Access, 23, pp. 849 - 860, http://dx.doi.org/10.1177/11297298211011375
,2022, 'Potential effects of lowering the threshold of statistical significance in the field of chronic rhinosinusitis – A meta-research on published randomized controlled trials over last decade', Brazilian Journal of Otorhinolaryngology, 88, pp. S83 - S89, http://dx.doi.org/10.1016/j.bjorl.2021.11.004
,2022, 'The ASCEND-ND trial: study design and participant characteristics', Nephrology Dialysis Transplantation, 37, pp. 2157 - 2170, http://dx.doi.org/10.1093/ndt/gfab318
,2022, 'The Reality of Inadequate Patient Care and the Need for a Global Action Framework in Organ Donation and Transplantation', Transplantation, 106, pp. 2111 - 2117, http://dx.doi.org/10.1097/TP.0000000000004186
,2022, 'An ISN-DOPPS Survey of the Global Impact of the COVID-19 Pandemic on Peritoneal Dialysis Services', Kidney International Reports, 7, pp. 2196 - 2206, http://dx.doi.org/10.1016/j.ekir.2022.07.013
,2022, 'Challenges in Diagnosis and Management of Glomerular Disease in Resource-Limited Settings', Kidney International Reports, 7, pp. 2141 - 2149, http://dx.doi.org/10.1016/j.ekir.2022.07.002
,2022, 'Clinical Trial Considerations in Developing Treatments for Early Stages of Common, Chronic Kidney Diseases: A ScientificWorkshop Cosponsored by the National Kidney Foundation and the US Food and Drug Administration', AMERICAN JOURNAL OF KIDNEY DISEASES, 80, pp. 513 - 526, http://dx.doi.org/10.1053/j.ajkd.2022.03.011
,2022, 'Evaluation and Management of Tuberculosis in Solid Organ Transplant Recipients: South Asian Expert Group Opinion', Indian Journal of Transplantation, 16, pp. S15 - S22, http://dx.doi.org/10.4103/ijot.ijot_18_22
,2022, 'Serum catalytic iron and progression of chronic kidney disease: findings from the ICKD study', Nephrology Dialysis Transplantation, 37, pp. 1879 - 1887, http://dx.doi.org/10.1093/ndt/gfab271
,2022, 'SGLT2 Inhibitors in the Management of Chronic Kidney Disease: An Expert Consensus', Journal of Association of Physicians of India, 70, pp. 68 - 76
,2022, 'SGLT2 Inhibitors in the Management of Chronic Kidney Disease: An Expert Consensus', The Journal of the Association of Physicians of India, 70, pp. 11 - 12, http://dx.doi.org/10.5005/japi-11001-0122
,2022, 'Post-vaccination analysis of anti-spike antibody responses in kidney transplant recipients with and without COVID-19 infection in a tertiary care centre, India', Clinical Kidney Journal, 15, pp. 1312 - 1321, http://dx.doi.org/10.1093/ckj/sfac057
,2022, 'Cholecalciferol supplementation and angiogenic markers in chronic kidney disease', PLoS ONE, 17, http://dx.doi.org/10.1371/journal.pone.0268946
,2022, 'Early Identification of CKD—A Scoping Review of the Global Populations', Kidney International Reports, 7, pp. 1341 - 1353, http://dx.doi.org/10.1016/j.ekir.2022.03.031
,